Literature DB >> 25277840

Expression of inflammatory markers in a genetic rodent model of depression.

Nina Strenn1, Petra Suchankova2, Staffan Nilsson3, Christina Fischer4, Gregers Wegener5, Aleksander A Mathé6, Agneta Ekman7.   

Abstract

The complex bidirectional communication between the central nervous system and the peripheral immune system is of possible relevance for both normal brain functions and the development of psychiatric disorders. The aim of this investigation was to study central expression of inflammatory markers in a genetic rat model of depression (the Flinders sensitive line (FSL) and its control, the Flinders resistant line (FRL)). A peripheral immune activation was induced by lipopolysaccharide (LPS) in order to investigate possible differences in immune reactions between the two rat lines. To confirm behavioural differences between the rat lines the forced swim test was performed, a test to assess depressive-like behaviour. Expression of candidate inflammatory genes was measured in amygdala, hippocampus, hypothalamus, prefrontal cortex and striatum using quantitative real time PCR. Our results show, for the first time, significantly lower central expression of the glial-specific protein S100B and complement factor C3 in several brain regions of the FSL rats compared to controls, both at baseline and after peripheral immune stimulation. No significant differences in immune responses to LPS were observed between the rats lines. Both S100B and C3 have been suggested to be of relevance for brain development and plasticity as well as brain disorders. These proteins may be of importance for the behavioural differences between the FSL and FRL rats, and this model may be useful in studies exploring the influence of the immune system on brain functions.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C3; Central gene expression; Flinders sensitive line; Immune system; S100B

Mesh:

Substances:

Year:  2014        PMID: 25277840     DOI: 10.1016/j.bbr.2014.09.025

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

Review 1.  Pathogenesis of depression: Insights from human and rodent studies.

Authors:  C Ménard; G E Hodes; S J Russo
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

2.  Total Saikosaponins Attenuates Depression-Like Behaviors Induced by Chronic Unpredictable Mild Stress in Rats by Regulating the PI3K/AKT/NF-κB Signaling Axis.

Authors:  Zhicong Zhou; Hui Chen; Xiaoyan Tang; Binghong He; Lingxia Gu; Huancun Feng
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-18       Impact factor: 2.650

3.  Changes of Serum Melatonin, Interleukin-6, Homocysteine, and Complement C3 and C4 Levels in Patients With Depression.

Authors:  Huai Tao; Xia Chen; Hongfei Zhou; Jinhua Fu; Qi Yu; Yong Liu
Journal:  Front Psychol       Date:  2020-06-23

4.  Antidepressant Mechanism Research of Acupuncture: Insights from a Genome-Wide Transcriptome Analysis of Frontal Cortex in Rats with Chronic Restraint Stress.

Authors:  Yu Wang; Huili Jiang; Hong Meng; Jing Li; XinJing Yang; Bingcong Zhao; Yang Sun; Tuya Bao
Journal:  Evid Based Complement Alternat Med       Date:  2017-09-26       Impact factor: 2.629

Review 5.  Neuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System.

Authors:  Ciro De Luca; Anna Maria Colangelo; Lilia Alberghina; Michele Papa
Journal:  Front Cell Neurosci       Date:  2018-11-26       Impact factor: 5.505

6.  Elevation of Il6 is associated with disturbed let-7 biogenesis in a genetic model of depression.

Authors:  Y B Wei; J J Liu; J C Villaescusa; E Åberg; S Brené; G Wegener; A A Mathé; C Lavebratt
Journal:  Transl Psychiatry       Date:  2016-08-16       Impact factor: 6.222

7.  Longitudinal assessment of S100B serum levels and clinical factors in youth patients with mood disorders.

Authors:  Aleksandra Rajewska-Rager; Monika Dmitrzak-Weglarz; Pawel Kapelski; Natalia Lepczynska; Joanna Pawlak; Joanna Twarowska-Hauser; Maria Skibinska
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.